Video Experimental Relacionado
Updated: Aug 1, 2026
06:42
Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
Published on: March 3, 2023
La investigación clínica patrocinada por la industria: una espada de doble filo
J S Montaner1, M V O'Shaughnessy, M T Schechter
1Canadian HIV Trials Network, University of British Columbia/St Paul's Hospital, 620-1081 Burrard Street, BC, V6Z 1Y6, Vancouver, Canada.
Lancet (London, England)
|December 14, 2001
Resumen
Desde la década de 1950, la investigación patrocinada por la industria ha impulsado una innovación terapéutica significativa. Esta tendencia está creando nuevos desafíos en las asociaciones académicas y de la industria.
Área de la Ciencia:
- Biotecnología y Ciencias Farmacéuticas.
- Descubrimiento y Desarrollo de Drogas.
Sus antecedentes:
- La década de 1950 marcó el comienzo del desarrollo acelerado de fármacos.
- Distinguir las contribuciones de la industria frente a la investigación gubernamental es un desafío.
- La biotecnología y las industrias farmacéuticas son los principales impulsores de la innovación terapéutica.
Objetivo del estudio:
- Analizar el impacto del patrocinio de la industria en el desarrollo de fármacos.
- Examinar la relación en evolución entre las instituciones académicas y la industria.
Principales métodos:
- Análisis cualitativo de las tendencias históricas en el desarrollo de drogas.
- Revisión de los modelos de financiación de la investigación en el sector farmacéutico.
Principales resultados:
- Las innovaciones terapéuticas se han derivado en gran medida de los esfuerzos patrocinados por la industria.
- El aumento del patrocinio de la industria ha introducido nuevas dinámicas y tensiones en las colaboraciones académico-industrial.
Conclusiones:
- El patrocinio de la industria es una fuerza importante en el desarrollo moderno de fármacos.
- La creciente influencia de la industria requiere una reevaluación de las relaciones académico-industrial.
Palabras clave:
Investigaciones biomédicas y conductuales.
Videos de Conceptos Relacionados
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...